Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vimab Group AB (OSTO:VIMAB) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Vimab Group AB's Enterprise Value for the quarter that ended in Mar. 2026 was kr231.4 Mil.
Vimab Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-70.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimab Group AB EV-to-EBIT Related Terms
Vimab Group AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Vimab Group AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:VIMAB vs VRSK, EFX, BAH: EV-to-EBIT Comparison
For the Consulting Services subindustry, Vimab Group AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimab Group AB EV-to-EBIT vs Business Services Industry
For the Business Services industry and Industrials sector, Vimab Group AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Vimab Group AB's EV-to-EBIT falls into.
Vimab Group AB's current Enterprise Value is kr207.1 Mil.
Vimab Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-70.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimab Group AB (OSTO:VIMAB) has a EV-to-EBIT of -2.92 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vimab Group AB and its competitors. According to the industry distribution chart, Vimab Group AB ranks #999999 out of 855 companies in the Business Services industry.
Is Vimab Group AB's EV-to-EBIT too high?
Vimab Group AB's current EV-to-EBIT is -2.92. Based on the distribution chart, Vimab Group AB ranks #999999 out of 855 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Vimab Group AB has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's EV-to-EBIT compare to VRSK and EFX?
According to the Business Services industry distribution chart, Vimab Group AB ranks #999999 out of 855 companies for EV-to-EBIT. This places Vimab Group AB in the lower half of its industry. The industry median EV-to-EBIT is 11.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Business Services company?
The median EV-to-EBIT among Business Services companies is 11.15, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vimab Group AB and its competitors. For the Business Services industry, the median EV-to-EBIT is 11.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimab Group AB's current EV-to-EBIT is -2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Modestly Undervalued. The stock's GF Value™ is kr5.89, compared to a current price of kr4.42 — trading 25% below its estimated fair value. The current EV-to-EBIT is -2.92. Vimab Group AB's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current EV-to-EBIT is -2.92 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued.
The current stock price of kr4.42 is trading 25% below its estimated GF Value™ of kr5.89.
GuruFocus considers Vimab Group AB to be Modestly Undervalued.
Key valuation signals for OSTO:VIMAB:
EV-to-EBIT: -2.92
GF Value™: kr5.89 vs. price of kr4.42 (25% below fair value)
No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
55GF Score
Get the complete analysis for OSTO:VIMAB
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:VIMAB has been successfully added to your 
